A placebo-controlled study of three agomelatine dose regimens (10mg, 25mg, 25–50mg) in patients with major depressive disorder

The Hospital Anxiety and Depression Scale

A. S. Zigmond, R. P. Snaith · Acta Psychiatrica Scandinavica · 1983 · 46.6K citations

Social Sciences, Psychiatry, Psychology +13

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

David V. Sheehan · The Journal of Clinical Psychiatry · 1998 · 19.4K citations

Medicine, Behavioral Sciences, Psychiatry +14

ECDEU Assessment Manual for Psychopharmacology

William Guy · Bulletin of Miscellaneous Information (Royal Gardens Kew) · 1976 · 8.8K citations

Medicine, Pharmacology, Psychiatry +7

Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT2C antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study

Henri L o, Anthony S. Hale, H. D haenen · International Clinical Psychopharmacology · 2002 · 362 citations

Medicine, Pharmacology, Psychiatry +15

Fixed-Dose Trial of the Single Isomer SSRI Escitalopram in Depressed Outpatients

W. J. Burke, I. Gergel, Anjana Bose · The Journal of Clinical Psychiatry · 2002 · 357 citations

Medicine, Pharmacology, Pharmacotherapy +16